Iterum Therapeutics plc is dedicated to developing significantly differentiated anti-infectives aimed at combating the global crisis of multi-drug resistant (MDR) pathogens. Our goal is to develop solutions that significantly improve the lives of people affected by serious and life-threatening diseases around the world. We are focused on executing a business development strategy via product/company acquisitions and strategic alliances.
Iterum Therapeutics plc welcomes inquiries regarding potential opportunities for collaboration across development and commercialization.
If you would like to submit business development opportunities to Iterum Therapeutics plc, please send all inquiries to BD@iterumtx.com or call 312-778-6070 (Select Option 2).